Seegene Expands Precision Diagnostics for Women’s Health
SEOUL, South Korea, July 27, 2026 Seegene Inc., a global leader in molecular diagnostics, has introduced a comprehensive syndromic...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
SEOUL, South Korea, July 27, 2026 Seegene Inc., a global leader in molecular diagnostics, has introduced a comprehensive syndromic...
AMSTERDAM, Netherlands, June 2, 2026 Royal Philips has received U.S. FDA 510(k) clearance and CE Mark approval for Elevate...
FREMONT, Calif., Oct. 10, 2025 /PRNewswire/ — Alamar Biosciences, a leader in precision proteomics, today announced the launch of...
